Early diagnosis of Chronic Liver Disease - What does it mean for patients?
Online webinar | Monday 3 March | 17:30 - 18:10 CET
Webinar
Join us for the next LIVERAIM webinar as we uncover what patients really think about earlier diagnosis—the hopes, the fears, and the reality!
Chronic liver disease is a growing public health concern, and early diagnosis has the potential to transform patient outcomes and quality of life. But what does an early diagnosis truly mean for patients, families, and caregivers? How does this affect those with comorbidities, and how can patients navigate the challenges, and leverage the benefits of an early diagnosis towards better health?
Join us for an insightful multidisciplinary panel to explore the real impact of early detection with a focus on the potential to empower patients to take control of their health and support prevention. The panel will also discuss challenges such as health and digital literacy, access to care, and sustainable healthy lifestyle changes, with of course opportunity for audience interaction!
Key Themes:
-
How patients understand their diagnosis and the role of care providers, patient support groups and online communities.
-
The role of cultural and social determinants in shaping health behaviors
-
Challenges in accessing care and health information
-
The essential role of multidisciplinary teams in guiding patients through diagnosis, treatment, and management
Who should watch?
Patients and their families, patient associations, patient advocates, primary healthcare professionals, nurses, dietitians, gastroenterologists, hepatologists, and anyone interested in learning more about chronic liver disease from a patient’s perspective!
Moderator:
Alina M. Allen MD, MS, Associate Professor of Medicine , Director MASLD Clinic, Mayo Clinic (USA)
Panelists:
-
Mark Duman, Patient Engagement Pioneer, Strategic consulting for healthcare and life sciences. Lived experience of MASLD (UK)
-
Dr Helen Jarvis, GP Partner, Clinical Lecturer, UK Liver Alliance early detection lead, Primary care advisor to the British Liver Trust, Chair Lancet global commission on liver disease in primary care (UK)
-
Rogerio Ribeiro, Researcher and Patient Advocate at APDP Diabete (Portugal)
Past Webinars
Tackling the silent epidemic of chronic liver disease through early diagnosis and linkage to care: The LIVERAIM project
Online webinar | 12 Dec. | 17:30- 18:10 CET
Webinar
Did you know that tens of millions of people across Europe are unaware that they have liver disease?
Join us for the first webinar in our LIVERAIM series, and discover how this groundbreaking European project is going to revolutionise the early diagnosis and management of chronic liver disease.
Our engaging panel of expert speakers shares why there is a pressing need for innovation in liver disease diagnosis in the face of this under-addressed public health threat. Diving into the current epidemiological landscape of chronic liver disease, the speakers briefly highlight the serious human and economic impact on patients and health systems, as well as discuss the critical importance of early detection, followed by efficient linkage to care.
Attendees gain insights into the latest advancements in diagnostic technology, including novel biomarkers and non-invasive tests, as the speakers explore how these innovations transform existing screening and diagnostic protocols. The webinar also delves into the challenges of health system capacity and integrating new protocols into daily clinical care.
The LIVERAIM project places a strong emphasis on patient empowerment; the panel discusses why personalized treatment and holistic disease management are pivotal in improving patient outcomes.
There are opportunities for attendees to interact with the panelists, and questions from the audience are encouraged. Even the tough ones!
Key Takeaways:
- Understanding of the human and economic burden of chronic liver disease
- Leveraging early diagnosis in chronic liver disease and how the LIVERAIM project addresses this need
- Insights into novel biomarkers and non-invasive tools for more efficient screening
- Why patient engagement and improved health literacy are key to achieving long-term success.
Moderator:
Professor Jeffrey V. Lazarus, Head of the Public Health Liver Group, ISGlobal Spain / Professor of Global Health , CUNY Graduate School of Public Health and Health Policy, USA.
Panel:
- Professor Pere Ginès, Senior Consultant, Liver Unit, Hospital Clínic Barcelona/ Full Professor of Medicine in University of Barcelona (Spain)
- Professor Maja Thiele, MD, PhD, Hepatologist, Center for Liver Research, Odense University Hospital (Denmark)
- Professor Miquel Serra-Burriel, Health Economist, University of Zurich, (Switzerland)
- Milan Mishkovikj, Board Director, European Liver Patients Association (ELPA)